Citations 1
Archival vs new tumor samples for assessing PD-L1 expression in the KEYNOTE-010 study of pembrolizumab (pembro) vs docetaxel (doce) for previously treated advanced NSCLC.
Baas, Paul, Molina, Julian R. , Kim, Joo-Hang , Arvis, Catherine Dubos, Ahn, Myung‐Ju , Fidler, Mary J. , Surmont, Veerle, Castro, Gilberto de , Shentu, Yue , Dolled‐Filhart, Marisa, Im, Ellie, Herbst, Roy S. , Baas, Paul, Perez‐Gracia, José Luis , Felip, Enriqueta , Kim, Dong‐Wan , Han, Ji-Youn , Majem, Margarita , Garrido, Marcelo , Garon, Edward B.
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 3030-3030
